8 results match your criteria: "Almazov National Research Centre[Affiliation]"

Chronic myeloid leukemia (CML) is an oncological myeloproliferative disorder that accounts for 15 to 20% of all adult leukemia cases. The molecular basis of this disease lies in the formation of a chimeric oncogene BCR-ABL1. The protein product of this gene, p210 BCR-ABL1, exhibits abnormally high constitutive tyrosine kinase activity.

View Article and Find Full Text PDF

A Genome of Temperate Bacteriophage Placed in a Space of Pooled Viral Dark Matter Sequences.

Viruses

January 2023

Scientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the WCRC "Center for Personalized Medicine", Institute of Experimental Medicine, 197022 Saint Petersburg, Russia.

In the human gut, temperate bacteriophages interact with bacteria through predation and horizontal gene transfer. Relying on taxonomic data, metagenomic studies have associated shifts in phage abundance with a number of human diseases. The temperate bacteriophage VEsP-1 with siphovirus morphology was isolated from a sample of river water using as a host.

View Article and Find Full Text PDF

The overuse of antibiotics has led to the emergence of resistant bacteria. A good alternative is silver nanoparticles, which have antibacterial activity against Gram-negative and Gram-positive bacteria, including multidrug-resistant strains. Their combination with already known antibiotics has a synergistic effect.

View Article and Find Full Text PDF

Two Novel Lytic Bacteriophages Infecting spp. Are Promising Candidates for Targeted Antibacterial Therapy.

Viruses

April 2022

Scientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the WCRC "Center for Personalized Medicine", Institute of Experimental Medicine, 197022 Saint Petersburg, Russia.

The rapid emergence of antibiotic resistance is of major concern globally. Among the most worrying pathogenic bacteria are vancomycin-resistant enterococci. Phage therapy is a highly promising method for controlling enterococcal infections.

View Article and Find Full Text PDF

Exosomes as Natural Nanocarriers for RNA-Based Therapy and Prophylaxis.

Nanomaterials (Basel)

February 2022

Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia.

Exosomes are natural nanocontainers actively secreted by the body's cells and transmitting molecular signals of various types to recipient cells. Cellular mechanisms of exosomes' biogenesis involve specific sorting of RNA for incorporation into them. As a result, the molecular composition of exosomes is closely related to the donor cell's functional state, and this makes exosomes an important diagnostic and prognostic marker in a number of diseases (primarily oncological).

View Article and Find Full Text PDF

A study of the peculiarities and a comparative analysis of the technologies used for the fabrication of elements of novel hybrid microfluidic biochips for express biomedical analysis have been carried out. The biochips were designed with an incorporated microfluidic system, which enabled an accumulation of the target compounds in a biological fluid to be achieved, thus increasing the biochip system's sensitivity and even implementing a label-free design of the detection unit. The multilevel process of manufacturing a microfluidic system of a given topology for label-free fluorometric detection of protein structures is presented.

View Article and Find Full Text PDF

In this study, we aimed to develop a technique for colloidal silver nanoparticle (AgNP) modification in order to increase their stability in aqueous suspensions. For this purpose, 40-nm spherical AgNPs were modified by the addition of either human albumin or Tween-80 (Polysorbate-80). After detailed characterization of their physicochemical properties, the hemolytic activity of the nonmodified and modified AgNPs was investigated, as well as their cytotoxicity and antimicrobial effects.

View Article and Find Full Text PDF

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Leukemia

April 2020

III. Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany.

The therapeutic landscape of chronic myeloid leukemia (CML) has profoundly changed over the past 7 years. Most patients with chronic phase (CP) now have a normal life expectancy. Another goal is achieving a stable deep molecular response (DMR) and discontinuing medication for treatment-free remission (TFR).

View Article and Find Full Text PDF